AMPYRA for Multiple Sclerosis – Pricing that will benefit the MS Patient

The wholesale acquisition cost is $1,065 per 30-day supply (one 60-count bottle).

What people will pay out-of-pocket will vary based on their insurance coverage, which won’t be determined until insurance companies finalize tiering, access, etc. (that timing varies from company to company, so we can’t give any kind of definitive date as to when that will be set).

A couple of points Acorda finds relevant to the pricing discussion:

o We are launching a comprehensive set of services to ensure broad access to AMPYRA for people with MS, all of which can be accessed through AMPYRA Patient Support Services (888-881-1918). This line is open now for anyone who wants to call with questions.

o Acorda’s goal is to ensure that cost is not a barrier to any person with MS who may benefit from this important medication, regardless of their level of income or healthcare coverage.

o Patients who meet income and other requirements, regardless of their insurance status, may receive AMPRYA at no cost. This may include individuals who have limited healthcare coverage.

o Acorda has also put a program in place to help individuals with private insurance manage their co-payment costs, where allowed by law. We will cover co-pay expenses over $40, regardless of income. My understanding is that Massachusetts is currently the only state that blocks this type of program.

o The support line will work with a person’s insurance company to facilitate access, and will also provide support on the appeals process if necessary.